The goal of this study was to determine the expression of SMC1 in triple negative breast cancer cells, including those that are BRCA1 mutated, as compared to normal or hormone receptor positive breast cancer cells. The gene discussed is SMC1A; the disease is triple-negative breast carcinoma.